MRVI - Maravai Lifesciences Holdings Inc logo

MRVI

Maravai Lifesciences Holdings Inc

Maravai Lifesciences Holdings develops and sells products for drug therapy, vaccines, cell and gene therapies, and diagnostics. Its offerings include nucleic acids, analysis kits, and custom services, serving biopharmaceutical firms and research institutions globally.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago $105today

Score Overview

1 Year
Score
Net Growth40.82%
Net TrendGrew
Net Income Consistency
Rev Growth12.40%
Rev TrendGrew
Revenue Consistency
5 Years
Score3.6
Net Growth-142.51%
Net Trend60%
Net Income Consistency
Rev Growth-73.88%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-200.65%
Net Trend67%
Net Income Consistency
Rev Growth-26.51%
Rev Trend50%
Revenue Consistency

See the full market ranking →

Maravai Lifesciences Holdings Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 284M to $ 185M and net income went from $ 76M to -$ 130M. Revenue increased in 2 of those 5 years; net income in 3.

Maravai Lifesciences Holdings Inc currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 5.78
1 Year2025-08-12
$ 2.69114.87%
5 Years2021-08-12
$ 55.12-89.51%
All Time2020-11-20
$ 29.85-80.64%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 208M-$ 77M$ 70M
2025$ 185M-$ 130M$ 216M
2024$ 259M-$ 144M$ 322M
2023$ 288M-$ 119M$ 574M
2022$ 883M$ 220M$ 632M
2021$ 799M$ 182M$ 551M
IPO2020$ 284M$ 76M$ 236M

Explore beyond MRVI

You're looking at Maravai Lifesciences Holdings Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies